Reflex

NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2024

Retrieved on: 
Wednesday, February 21, 2024

Reached the milestone of 500 AI-powered RTX games and applications utilizing NVIDIA DLSS, ray tracing and other NVIDIA RTX technologies.

Key Points: 
  • Reached the milestone of 500 AI-powered RTX games and applications utilizing NVIDIA DLSS, ray tracing and other NVIDIA RTX technologies.
  • NVIDIA will conduct a conference call with analysts and investors to discuss its fourth quarter and fiscal 2024 financial results and current financial prospects today at 2 p.m. Pacific time (5 p.m. Eastern time).
  • The webcast will be recorded and available for replay until NVIDIA’s conference call to discuss its financial results for its first quarter of fiscal 2025.
  • NVIDIA believes the presentation of its non-GAAP financial measures enhances the user’s overall understanding of the company’s historical financial performance.

CINEO LIGHTING UNVEILS NEW REFLEX R10 AT 2024 BSC EXPO

Retrieved on: 
Thursday, February 15, 2024

CHANDLER, Ariz., Feb. 15, 2024 /PRNewswire/ -- Cineo Lighting (www.cineolighting.com), an industry leader in innovative production lighting technology, announces the launch of its latest LED lighting product, the Cineo Reflex R10, at BSC Expo 2024. Expanding the Reflex series of LED production lighting, the Cineo Reflex R10 utilizes Cineo's patented liquid cooling and leading-edge LED technology to provide users with an IP X5-rated fixture that replaces legacy HMI and tungsten lights all in one sleek package. 

Key Points: 
  • Compact Cineo Reflex R10 liquid-cooled hard light joins Cineo's suite of products designed for production lighting professionals at BSC Expo 2024 Stand 355.
  • CHANDLER, Ariz., Feb. 15, 2024 /PRNewswire/ -- Cineo Lighting ( www.cineolighting.com ), an industry leader in innovative production lighting technology, announces the launch of its latest LED lighting product, the Cineo Reflex R10, at BSC Expo 2024.
  • Giving lighting professionals a compact LED fixture like no other without sacrificing quality," said Chuck Edwards, VP and Head of Cineo.
  • "The modular design of the Cineo Reflex R10 is an innovation for our users that allows this fixture to be future-proof, and as lighting technology evolves, the R10 can evolve with it," said Edwards.

CINEO LIGHTING UNVEILS NEW REFLEX R10 AT 2024 BSC EXPO

Retrieved on: 
Thursday, February 15, 2024

CHANDLER, Ariz., Feb. 15, 2024 /PRNewswire/ -- Cineo Lighting (www.cineolighting.com), an industry leader in innovative production lighting technology, announces the launch of its latest LED lighting product, the Cineo Reflex R10, at BSC Expo 2024. Expanding the Reflex series of LED production lighting, the Cineo Reflex R10 utilizes Cineo's patented liquid cooling and leading-edge LED technology to provide users with an IP X5-rated fixture that replaces legacy HMI and tungsten lights all in one sleek package. 

Key Points: 
  • Compact Cineo Reflex R10 liquid-cooled hard light joins Cineo's suite of products designed for production lighting professionals at BSC Expo 2024 Stand 355.
  • CHANDLER, Ariz., Feb. 15, 2024 /PRNewswire/ -- Cineo Lighting ( www.cineolighting.com ), an industry leader in innovative production lighting technology, announces the launch of its latest LED lighting product, the Cineo Reflex R10, at BSC Expo 2024.
  • Giving lighting professionals a compact LED fixture like no other without sacrificing quality," said Chuck Edwards, VP and Head of Cineo.
  • "The modular design of the Cineo Reflex R10 is an innovation for our users that allows this fixture to be future-proof, and as lighting technology evolves, the R10 can evolve with it," said Edwards.

Reflex Advanced Materials Corp. Announces Sale of ZigZag Property

Retrieved on: 
Tuesday, January 9, 2024

VANCOUVER, British Columbia, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp. (CSE:RFLX) (OTCQB:RFLXF) (FSE:HF2) (“Reflex” or the “Company”) is pleased to announce that it has sold a 100% interest in the ZigZag Lake Lithium Property (the “Property”), located near Crescent Lake, Ontario, to Integral Metals Corp. (the “Purchaser”) pursuant to a property purchase agreement dated January 8, 2024 (the “Purchase Agreement”).

Key Points: 
  • VANCOUVER, British Columbia, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp. (CSE:RFLX) (OTCQB:RFLXF) (FSE:HF2) (“Reflex” or the “Company”) is pleased to announce that it has sold a 100% interest in the ZigZag Lake Lithium Property (the “Property”), located near Crescent Lake, Ontario, to Integral Metals Corp. (the “Purchaser”) pursuant to a property purchase agreement dated January 8, 2024 (the “Purchase Agreement”).
  • Pursuant to the Purchase Agreement, the Purchaser has paid $400,000 to the Company and issued 1,000,000 common shares in the capital of the Purchaser (the “Consideration Shares”) in consideration for the Property.
  • In connection with the closing of the Property acquisition by the Purchaser, Reflex exercised its option in respect of the Property in accordance with the mineral property option agreement dated September 1, 2021, following which it conveyed title to the Property to the Purchaser pursuant to the Purchase Agreement.
  • No finder’s fees or commissions are being paid in connection with the sale of the Property.

Aegis Sciences Corporation Announces Expanded Testing for Marijuana

Retrieved on: 
Tuesday, December 5, 2023

Aegis Sciences Corporation , a health care testing lab based in Nashville, Tenn., is pleased to announce it will be updating their urine testing for marijuana and other cannabinoids to include Delta‐8 Carboxy‐THC and Cannabidiol, in addition to Delta‐9 Carboxy‐THC.

Key Points: 
  • Aegis Sciences Corporation , a health care testing lab based in Nashville, Tenn., is pleased to announce it will be updating their urine testing for marijuana and other cannabinoids to include Delta‐8 Carboxy‐THC and Cannabidiol, in addition to Delta‐9 Carboxy‐THC.
  • The interpretation of marijuana results differs when considering presumptive vs definitive testing.
  • Aegis’s assay will continue to undergo presumptive testing by immunoassay with reflex to definitive testing by mass spectrometry.
  • “Expanding our marijuana assay to include other cannabinoids demonstrates our commitment to providing the most relevant testing available to healthcare providers,” said Dr. Rebecca Heltsley, Senior Vice President, Research and Development at Aegis Sciences Corporation.

Feinstein Institutes’ Dr. Kevin J. Tracey receives 2023 Hans Wigzell Research Foundation's Science Prize

Retrieved on: 
Thursday, November 2, 2023

The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.

Key Points: 
  • The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.
  • Dr. Tracey will travel to Stockholm, Sweden, to receive the prize, which includes $100,000, and deliver a lecture on December 1.
  • View the full release here: https://www.businesswire.com/news/home/20231102553265/en/
    Dr. Kevin J. Tracey has been named awardee of the 2023 Hans Wigzell Research Foundation's Science Prize.
  • “The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop inflammatory diseases,” said Hans Wigzell, MD, PhD, on behalf of the Hans Wigzell Research Foundation.

Hello hay fever – why pressing under your nose could stop a sneeze but why you shouldn't

Retrieved on: 
Thursday, October 26, 2023

It is a protective reflex action outside our conscious control, to remove irritants from inside our nose.

Key Points: 
  • It is a protective reflex action outside our conscious control, to remove irritants from inside our nose.
  • You can sometimes stop a sneeze by holding your nose or pressing underneath it.
  • But given the velocity of a sneeze, it might not be a good idea to stop it after it has started.

An involuntary reflex

  • When a threshold amount of irritant signals reach the brain, the sneeze reflex is triggered.
  • A sneeze first involves a deep intake of breath and a build-up of pressure inside the airways.
  • This is then followed by contraction of the diaphragm and rib muscles, reflex closing of the eyes and a strong exhalation.

The trigeminal nerves

  • The trigeminal nerves are the largest of our 12 pairs of cranial nerves and the largest sensory nerves in the body.
  • The left and right trigeminal nerves carry sensory information from the face to the brain.

Sensory nerves communicate in the spinal cord

  • Sensory nerves travel to the brain via the spinal cord.
  • The sensory nerves that carry pain and irritant signals are narrow, whereas those that carry touch information are wider and faster.
  • In the spinal cord, these nerves communicate with each other via interneurons before sending their message to the brain.

So does putting your finger under your nose stop a sneeze?

  • These include pulling your ear, putting your tongue to the roof of your mouth or the back of your teeth, touching your nose, or even sticking your finger in your nose.
  • Read more:
    Forget nose spray, good sex clears a stuffy nose just as effectively — and is a lot more fun

But should you stop a sneeze?

  • Should you stop it?
  • Closing your mouth or nose during a sneeze increases the pressure in the airways five to 20 times more than a normal sneeze.
  • With no escape, this pressure has to be transmitted elsewhere and that can damage your eyes, ears or blood vessels.


The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

New StellaPro Reflex S Hybrid Light Delivers 50% More Burst and Continuous Power, Doubles Current Run Time, and supports 30 FPS

Retrieved on: 
Friday, September 29, 2023

MARINA, Calif., Sept. 28, 2023 /PRNewswire-PRWeb/ -- MARINA, CA – September 28, 2023 – StellaPro Lights announces a major update to its award-winning Reflex S Continuous Strobe Hybrid LED photo/video light. The Reflex S, now with a more powerful battery handle, delivers 50% more burst power, twice the run time and 50% more continuous power than the original. The result is a light that is 50% faster, generating 30 frames a second in full power bursts 1 – without misfires -- compared to 20 frames a second with the original battery.

Key Points: 
  • StellaPro Lights has unveiled a significant update to its award-winning Reflex S Continuous Strobe Hybrid LED photo/video light.
  • MARINA, Calif., Sept. 28, 2023 /PRNewswire-PRWeb/ -- MARINA, CA – September 28, 2023 – StellaPro Lights announces a major update to its award-winning Reflex S Continuous Strobe Hybrid LED photo/video light .
  • The Reflex S, now with a more powerful battery handle, delivers 50% more burst power, twice the run time and 50% more continuous power than the original.
  • "This major update to Reflex S delivers a dramatic increase in power, run time, and burst performance from a light that is smaller and lighter than any hybrid light on the market today," 2 Emerson added.

Benchmarking Study Shows Streamlined Structural Variant Detection and High Concordance for OGM Compared to Chromosomal Microarray Analysis, the Global Standard in Genetic Disease Analysis

Retrieved on: 
Thursday, September 28, 2023

SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first peer-reviewed benchmarking study to compare optical genome mapping (OGM) to the current global standard in molecular analysis of constitutional genetic disorders, chromosomal microarray analysis (CMA).

Key Points: 
  • SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first peer-reviewed benchmarking study to compare optical genome mapping (OGM) to the current global standard in molecular analysis of constitutional genetic disorders, chromosomal microarray analysis (CMA).
  • Additionally, KT and FISH are needed as a reflex when researchers must confirm a translocation or locate a duplication.
  • The gap between long-read sequencing and CMA is even greater than the gap between short-read WGS and CMA.
  • It is important for the research community to have a benchmarking study comparing OGM to CMA, especially for genetic disorders, since OGM has a comparatively cost-effective workflow with simple interpretation and analysis.

As countries around the world accelerate their genome-based testing readiness, Canada's health systems can't afford to fall behind

Retrieved on: 
Wednesday, September 13, 2023

Alberta is followed by Quebec, British Columbia, Nova Scotia, and Ontario, ranked in order of their readiness grade.

Key Points: 
  • Alberta is followed by Quebec, British Columbia, Nova Scotia, and Ontario, ranked in order of their readiness grade.
  • "I feel like I'm living on borrowed time, and it has been tough on my family, knowing things could have been different.
  • Some of these tangible policy actions include:
    Developing province wide education and training standards to ensure consistency in the quality of testing service.
  • To make their health systems more resilient, countries around the globe are accelerating their progress on genome-based testing.